Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
企業コードAORT
会社名Artivion Inc
上場日Feb 12, 1993
最高経営責任者「CEO」Mr. James Patrick (Pat) Mackin
従業員数1600
証券種類Ordinary Share
決算期末Feb 12
本社所在地1655 Roberts Boulevard N W
都市KENNESAW
証券取引所NYSE Consolidated
国United States of America
郵便番号30144
電話番号17704193355
ウェブサイトhttps://artivion.com/
企業コードAORT
上場日Feb 12, 1993
最高経営責任者「CEO」Mr. James Patrick (Pat) Mackin
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし